The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors

Lab / animal OA: closed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-17 ⓘ

The compound D 15413 inhibited the growth of estrogen-dependent mammary tumors in rat and mouse models and reduced the proliferation of estrogen receptor-positive breast cancer cells in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-03 · read from full text ⓘ

This study evaluated the antineoplastic activity of D 15413, a hydroxyphenyl indole compound, across multiple estrogen-dependent mammary tumor models in rats and mice. The results demonstrated that oral administration of D 15413 significantly inhibited tumor growth in DMBA-induced rat carcinomas, MNU-induced rat tumors, and transplanted mouse MXT tumors, while also suppressing the proliferation of estrogen receptor-positive MCF-7 human breast cancer cells in vitro. The authors propose that the mechanism of action involves both endocrine modulation and direct cytotoxic effects on tumor cells. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The antineoplastic activity of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) was determined in several estrogen-dependent mammary tumor models. The growth of DMBA-induced rat mammary carcinomas was inhibited by doses ranging from 2 to 18 mg/kg. A dose of 6 X 12 mg/kg per week p.o. reduced the tumor area by 82% (control + 192%). D 15413 was also active against MNU-induced rat mammary tumors and transplanted MXT tumors of the mouse. In vitro, the growth of estrogen receptor positive MCF-7 breast cancer cells was inhibited by D 15413 (10(-8) - 10(-5) M). A mode of action considering endocrine and cytotoxic effects is discussed.
Full text 3,667 characters · extracted from oa-doi-fallback · click to expand
Summary The antineoplastic activity of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) was determined in several estrogen-dependent mammary tumor models. The growth of DMBA-induced rat mammary carcinomas was inhibited by doses ranging from 2 to 18 mg/kg. A dose of 6×12 mg/kg per week p.o. reduced the tumor area by 82% (control+192%). D 15413 was also active against MNU-induced rat mammary tumors and transplanted MXT tumors of the mouse. In vitro, the growth of estrogen receptor positive MCF-7 breast cancer cells was inhibited by D 15413 (10−8–10−5 M). A mode of action considering endocrine and cytotoxic effects is discussed. Similar content being viewed by others References Angerer E von (1984) Development of new drugs for endocrine tumour chemotherapy. Cancer Treat Rev 11 (Suppl. A): 147–153 Angerer E von, Prekajac J (1983) Hydroxyphenyl indoles: a new class of mammary tumor inhibiting compounds. J Med Chem 26:113–116 Angerer E von, Prekajac J, Strohmeier J (1984) 2-Phenyl-indoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. J Med Chem 27:1439–1447 Angerer E von, Prekajac J, Berger M (1985) The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors. Eur J Cancer Clin Oncol 21:531–537 Black LJ, Goode RL (1980) Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY 117018) in rats and mice. Life Sci 26:1453–1458 Koziol AJ, Donna AM (1981) A distribution-free test for tumor growth curve analysis with application to an animal tumor growth curve analysis with application to an animal tumor immunotherapy experiment. Biometrics 37:383–390 Leclercq G, Danguy A, Heuson JC (1984) MXT mouse mammary tumor: growth inhibition by tamoxifen or oestrogen administration. IRCS Med Sci 12:218–219 Maass H, Jonat W, Stolzenbach G, Trams G (1980) The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer. Cancer 46:2783–2787 Mann HB, Whitney DR (1947) On a test whether one or two random variables is stochastically larger than the other. Am Math Statist 18:50–60 Nagasawa H, Nozaki D, Niki K, Namiki K (1985) Effects of 2-(hydroxyphenyl)indoles on the formation of preneoplastic mammary hyperplastic alveolar nodules and uterine adenomyosis in SHN virgin mice. Mem Inst Techn, Meiji Univ in press Ogasawara J, Okamoto S, Kitamura J, Matsumoto K (1983) Proliferative pattern of uterine cells from birth to adulthood in intact, neonatally castrated and/or adrenalectomized mice, assayed by incorporation of [125I]iododeoxyuridine. Endocrinology 113:582–587 Richter A, Sandford KK, Evans VJ (1972) Influence of oxygen and culture medium on plating efficiency in some mammalian tissue culture cells. J Natl Cancer Inst 49:1705–1712 Scholl SM, Huff KK, Lippman ME (1983) Antiestrogenic effects of LY 117018 in MCF-7 cells. Endocrinology 113:611–617 Author information Authors and Affiliations Additional information Dedicated to Professor D. Schmähl on the occasion of his 60th birthday Supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 234, and by the Verband der Chemischen Industrie, Fonds der Chemischen Industrie Rights and permissions About this article Cite this article von Angerer, E., Prekajac, J., Schneider, M.R. et al. The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors. J Cancer Res Clin Oncol 110, 216–220 (1985). https://doi.org/10.1007/BF00399276 Received: Accepted: Issue date: DOI: https://doi.org/10.1007/BF00399276

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Antineoplastic Agents Indoles Mammary Neoplasms, Experimental Animals Antineoplastic Agents Cell Line Estrogens Estrogens Indoles Mammary Neoplasms, Experimental Mice Neoplasms, Hormone-Dependent Neoplasms, Hormone-Dependent Rats

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-04T09:26:46.659050+00:00
pubmed
last seen: 2026-10-08T21:50:50.276477+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00